Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Sanomedics International Holdings, Inc.
The revolutionary new device continues to gain traction in the Clinical Marketplace with new agreement to supply Novation, which operates 40 percent of the staffed beds in the United States!
SAN DIEGO, July 16, 2014 /PRNewswire/ -- Sanomedics, Inc. (OTCQB: SIMH); Sanomedics, a medical technology holding company that focuses on providing game changing products, services and ideas, announced today that their Thermomedics subsidiary recently strengthened its penetration of the Professional Healthcare vital signs business with the signing of a long-term agreement with Novation, a world-renowned provider of healthcare supply chain expertise and contracting. The 3-year agreement goes into effect October 1, 2014.
Based in Irving, Texas, Novation serves more than 100,000 members of VHA, Inc. and UHC (two national healthcare alliances), Children's Hospital Association (an alliance of the nation's leading pediatric facilities), and Provista, LLC, and operates 40 percent of the staffed beds in the United States. Novation accounted for $43 billion in annual purchases in 2012, handles 45% of the nation's admissions and represents 94% of the nation's academic medical centers.
Novation's markets include acute care hospitals and systems, academic medical centers, pediatric facilities, ambulatory care, physician clinics, home health and long-term care facilities. Through Provista, Novation also serves the education and corporate segments.
Keith Houlihan, the Company's President, commented, "This arrangement helps to confirm the growing demand for the Caregiver Thermometer's unique combination of accuracy, ease-of-use, reduced cross-contamination, speed, and cost-savings for Novation's broad base of hospitals, medical offices, clinics, long-term care sites, and all aspects of the continuum of care. Given its competitive pricing model and the fact that no costly probe covers are required for it to deliver results, we're confident that Caregiver is the superior choice among thermometers in the market today and look forward to seeing increased interest in and adoption of it through this strategic partnership."
"The Caregiver's ability to perform in the high patient-volume environment of today's healthcare venues is enhanced by the availability of the items that hospitals have demanded: convenient mounting systems, security protection, in-house biomedical calibration support, and attractive service/warranty programs," noted Ron Benincasa, Executive VP of Marketing and Sales. "This 3-year contract (with renewable 2-year options) will ensure that Novation will be at the forefront of innovative thermometry."
Distribution will be handled by the Ameritus division of Kentec Medical, Thermomedics' supply partner. Designed and developed by the team that first invented Infrared Tympanic Thermometry, led by Thermomedics' Chief Technical Officer, Gary O'Hara, the Caregiver is becoming a primary choice of hospitals and clinics across the nation.
About Sanomedics International Holdings, Inc.
Sanomedics International Holdings, Inc. (OTCQB: SIMH) is a medical technology holding company that focuses on game changing products, services and ideas -- a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.
Forward Looking Statements
This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties (for example, the risk that the acquisition is not consummated), and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company's periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.
Keith Houlihan, President
©2012 PR Newswire. All Rights Reserved.